NCT06023953View on ClinicalTrials.gov

Migraine With and Without Aura Characteristics and Response to Remote Electrical Neuromodulation (REN) Treatment

CompletedOBSERVATIONAL
Enrollment

31,715

Participants

Timeline

Start Date

July 1, 2023

Primary Completion Date

September 30, 2024

Study Completion Date

December 1, 2024

Conditions
Migraine With AuraMigraine Without Aura
Interventions
DEVICE

Nerivio device

REN treatment with Nerivio device

Trial Locations (1)

4520438

Theranica Bio-Electronics Ltd, Netanya

Sponsors

Lead Sponsor

Theranica
All Listed Sponsors
lead

Theranica

INDUSTRY

NCT06023953 - Migraine With and Without Aura Characteristics and Response to Remote Electrical Neuromodulation (REN) Treatment | Biotech Hunter | Biotech Hunter